Medico Intercontinental Ltd

Medico Intercontinental Ltd has re-appointed M/s. MJV & Co, Chartered Accountants, Ahmedabad, as its Internal Auditor for the financial year 2026-27. The decision was approved by the Board of Directors in their meeting held on May 22, 2026. The disclosure is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.

Medico Intercontinental Ltd. approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026, along with the auditor's report by M/s. V Goswami & Co. The board also approved the re-appointment of M/s. MJV & Co as Internal Auditor for FY 2026-27 and various company policies. The board meeting was held on May 22, 2026, from 12:30 PM to 12:50 PM.

Medico Intercontinental Ltd's board approved the audited standalone and consolidated financial results for the quarter and financial year ended March 31, 2026. The board also approved the re-appointment of M/s. MJV & Co as the Internal Auditor for FY 2026-27 and various company policies. The meeting, based on the recommendation of the Audit Committee and Nomination and Remuneration Committee, took place on May 22, 2026.

Medico Intercontinental Ltd has announced the closure of the 'Trading Window' for dealing in the securities of the company. This closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and BSE Limited's circular no. LIST/COMP/01/2019-20 dated 2nd April, 2019. The closure will be effective from 1st April, 2026 and will remain in force for all designated persons and their immediate relatives until 48 hours after the declaration of the audited financial results for the quarter and financial year ending March 31, 2026. All designated persons and their immediate relatives have been advised not to trade in the securities of the company during this period.

Medico Intercontinental Ltd has announced its unaudited standalone and consolidated financial results for the quarter and nine months ended December 31, 2025. The company's revenue from operations stands at Rs. 5,07,507 lakhs for the quarter and Rs. 1,40,47,631 lakhs for the nine months period. The profit for the period from operations before tax is Rs. 288,150 lakhs for the quarter and Rs. 6,26,100 lakhs for the nine months period. The company is operating in a single segment and has continued with old Income Tax rates for the current quarter.

Medico Intercontinental Ltd has announced the closure of the 'Trading Window' for dealing in the securities of the company. The closure is in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015 and BSE Limited's circular no. LIST/COMP/01/2019-20 dated 24 April, 2019. The window will be closed for all designated persons and their immediate relatives from 1st January, 2026 till 48 hours after the declaration of unaudited financial results for the quarter and nine months ended December 31, 2025. This decision is to prevent trading during the period when the company's financial results are not yet disclosed.

Samir Dilipkumar Shah has acquired 1,97,285 shares of Medico Intercontinental Ltd (MIL) through open market purchases on 24th December, 2025. This acquisition results in a change in shareholding patterns and increases Samir Dilipkumar Shah's holding to 46.40% and the PACs' holding to 12.68% of the total voting rights in the company.

Medico Intercontinental Ltd. has received a disclosure from its Promoter and Managing Director, Mr. Samir Dilipkumar Shah, regarding the acquisition of 1,97,285 shares of the company. The acquisition was made through an open market purchase on 24th December, 2025. The company has enclosed a copy of the disclosure and requested to take it on record.

Medico Intercontinental Ltd has announced its unaudited standalone and consolidated financial results for the quarter and half year ended on September 30, 2025. The company's revenue, expenses, and net profit have been reported in the financial statements, which were approved by the Board of Directors in a meeting held on November 14, 2025. The results have been prepared in accordance with the Ind AS notified under the Companies (Indian Accounting Standards) Rules 2015.

Medico Intercontinental Ltd. held a Board meeting on November 14, 2025, where they considered and approved the unaudited standalone and consolidated financial results for the quarter and half year ended on September 30, 2025. The results were reviewed by the Audit Committee and approved by the Board of Directors. The company is currently operating in a single segment, and it has continued with old income tax rates for the current quarter.